Skip to content

Characterization of a Novel Endolysin Sb1-LysAEJ as a Biocide and Food-contact Surface Disinfectant for the Control of Staphylococcus aureus.

Aug 2026 · Probiotics and Antimicrobial Proteins · 0 citations · 35 references
Medicine

TL;DR

LysAEJ demonstrates excellent specificity and antimicrobial activity, making it a promising biocontrol agent against S. aureus and its biofilms in diverse food processing environments.

View source

Similar papers

Sep 2026

Characterization of the phage lysin LYS176 targeting Staphylococcus aureus and its antibacterial activity in food.

Lysin LYS176, derived from Staphylococcus aureus (S. aureus) bacteriophage, exerts its bactericidal effect by hydrolyzing peptidoglycan within the bacterial cell wall, leading to rapid cell lysis. Lysin LYS176 exhibited antibacterial activity against 62 strains of S. aureus and maintained strong lytic activity within t...

Xin-Yan Yao, Chao-Xiang Jia, Ting Qin et al. · 0 citations
Open access Sep 2026

Comprehensive characterization of Staphylococcus phage SAP_2 as a safe and effective biocontrol agent against methicillin-resistant Staphylococcus aureus

The potential of SAP_2 as a biocontrol candidate for controlling MRSA contamination in milk is supported and good biosafety and reduced bacterial burdens in MRSA-infected mice are exhibited.

Dong-Xin Ma, Shuai-Feng Gu, Yu-Qiang Zhang et al. · 0 citations
Open access Aug 2026

Endolysin LysPEF52H from Enterococcus faecalis phage PEF-SWUN52H: a potential antibacterial agent

This study depicted and characterized the phage-derived endolysin LysPEF52H, providing a new alternative antimicrobial strategy for controlling bacterial contamination and ensuring food safety. The molecular weight of endolysin LysPEF52H was predicted using an online platform, and its three-dimensional (3D...

Jinling Wang, Yangyang Yang, Haijun Xu et al. · 0 citations
Open access Sep 2026

Antibacterial activity of a newly identified phage-derived endolysin and its parental bacteriophage against clinical uropathogenic Escherichia coli

The increasing prevalence of antibiotic-resistant uropathogenic Escherichia coli highlights the need for antibacterial strategies that can complement or extend beyond conventional antibiotic treatment. Bacteriophages and phage-derived lytic enzymes represent promising alternatives because of their distinct mechanisms o...

Wojciech Wesołowski, Sylwia Bloch, Grzegorz Czerwonka et al. · 0 citations
Open access Sep 2026

Endolysin LysSte134_1 Reduces Staphylococcus Bacterial Load in Infected Wounds In Vivo

Staphylococcus aureus is an ESKAPE pathogen, defined by its ability to evade antibacterial treatment, and together with S. epidermidis is a leading Gram-positive cause of wound infection. The emergence of methicillin- and vancomycin-resistant strains further limits conventional antibiotic treatment. The staphylococcal...

N. Golosova, Y. Khlusevich, B. Kravchuk et al. · 0 citations
Sep 2026

Isolation and Characterization of Lytic Bacteriophages Targeting Clinical Staphylococcus Other Than S. aureus.

Staphylococcus spp., other than S. aureus (SOSA, formerly CoNS), are opportunistic pathogens often linked to biofilm infections on indwelling devices. Their rising antibiotic resistance highlights the need for novel therapies. Bacteriophages are promising due to their specificity and ability to inhibit cell growth and...

Gerardo Antonio Romero-Borja, Luis Enrique Jiménez-Camacho, Victoria Abigail Sánchez-Herrera et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.